\"

Conference Day 2

8:30 AM - 8:55 AM Registration and Coffee

8:55 AM - 9:00 AM Chairman's Opening Address

9:00 AM - 9:40 AM Case Study: Setting the Standard for Plasmid DNA Production

  • Hear about a ready to use platform for fast track pDNA supply
  • Examine the different scale up of pDNA manufacturing technologies
  • Learn about the production of antibiotic resistance free plasmids

9:40 AM - 10:20 AM Cost Efficiency For Allogenic Production

  • Highlight what strategic points need to be considered when addressing the challenges that arise with increasing production
  • Examine how to implement scalable and standardised manufacturing methods
  • Determine what regulatory aspects need to be considered when strategising towards increasing production

10:20 AM - 10:50 AM Coffee Break

10:50 AM - 11:30 AM Utilizing Closed System Processing For Cell Therapy Manufacturing

  • Decipher what challenges will arise when implementing a closed system process
  • Hear a case study on how the adoption of closed systems across cell therapy manufacturing processes improved QA
  • Design protocols to transition from open to closed-system manufacturing

11:30 AM - 12:10 PM Roundtable Discussions

Choose from 6 different round table discussions to participate in, each facilitated by a leading industry figure

Roundtable 1: Effective advanced therapy production
Roundtable 2: Choosing the right starting material for cell and gene production
Roundtable 3: Identifying risk based strategy for commercialising cell and gene therapies
Roundtable 4: Determining the scale up opportunities for allogenic therapy production
Roundtable 5: How will patient view and accessibility improve cost of autologous production
Roundtable 6: Research Development for Cellular Therapy Production


12:10 PM - 1:10 PM Lunch

1:10 PM - 1:50 PM Case Study: Optimising Manufacturing Opportunities For Allogenic Production

  • Learn how to prevent cross contamination of allogenic products in manufacturing
  • Scrutinise how to achieve high level efficiency in producing “off the shelf” industrial product
  • Hear the latest initiatives in overcoming challenges faced with multiple product manufacturing

1:50 PM - 2:30 PM Case Study: Plasmid and Vector Manufacturing Techniques

  • Hear how vectors, including adenovirus, adeno-associated virus and lenti virus, can be safely generated
  • Determine how to design viral vectors for medicinal products
  • Plan your production around issues and considerations needed to be addressed before establishing a GMP compliant gene therapy protocol

2:30 PM - 3:00 PM Coffee Break

3:30 PM - 4:10 PM The Logistics of Advanced Therapy Manufacturing

  • Choose the right approach for building a successful logistics strategy
  • Compare the difference between autologous and allogenic logistic requirements
  • Anticipate what potential challenges can arise throughout the supply chain

4:10 PM - 4:50 PM Case study: How To Enhance Manufacturing Processes With The Move Between Open and Closed Manufacturing

4:50 PM - 5:00 PM Chairman's Closing Address